Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | December 2, 2020 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â COVID-19, Image credit: CDC, Top 5, VaccineÂ
EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe – Published on 01/12/20
Hopes are high for Pfizer and BioNTech’s vaccine after it recently demonstrated 95% efficacy in global Phase 3 trials, with this efficacy maintained in at-risk groups such as over-65s.
Analysis confirms Moderna’s COVID-19 vaccine efficacy to be 94.1% – Published on 30/11/20
On the back of the analysis, Moderna announced its intention to submit requests today with the FDA for Emergency Use Authorization, and for conditional approval from the EMA.
UK secures another two million COVID-19 vaccine doses from Moderna – Published on 30/11/20
This latest agreement, signed on 29 November, means the UK has earmarked seven million doses of the biotech’s therapy in total, meaning 3.5 million UK citizens could be vaccinated on Moderna’s two-dose vaccine alone.
New trial expected for AstraZeneca’s COVID-19 vaccine – Published on 27/11/20
AstraZeneca is expected to launch new global trials to assess the efficacy of its COVID-19 vaccine using a lower dosage.
Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa – Published on 25/11/20
Titled the ANTICOV trial, it sees 13 African countries join forces with research institutions to identify treatments that could treat the virus early and stop hospitals from becoming overwhelmed.
Related Content
BioNet receives positive EMA opinion on new pertussis vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use …
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
